Skip To Main Content
Lilly
Menu closed
Lilly
  • Account Login / Register
  • Medical Home
    • Medical Information
  • Medical Education
  • Science
Ask Lilly

We're here to help.

Chat
Chat with us Chat with us
Question Contact Us
Expand contact lilly
Lilly

You are now leaving the Lilly Medical website

The link you clicked on will take you to a site maintained by a third party, which is solely responsible for its content. Lilly USA, LLC does not control, influence, or endorse this site, and the opinions, claims, or comments expressed on this site should not be attributed to Lilly USA, LLC. Lilly USA, LLC is not responsible for the privacy policy of any third-party websites. We encourage you to read the privacy policy of every website you visit.
Click "Continue" to proceed or "Return" to return to Lilly Medical

  1. Medical Information Right
  2. Oncology Right
  3. Inluriyo (imlunestrant) tablets Right
  4. How should Inluriyo™ (imlunestrant) tablets be stored?
Search Inluriyo (type in keywords)
Search Medical Information

If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)

Loading icon

Inluriyo ™ (imlunestrant) tablets

200 mg

Full Prescribing Information

This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.

How should Inluriyo™ (imlunestrant) tablets be stored?

Store Inluriyo (imlunestrant) tablets at 68°F to 77°F (20°C to 25°C). Excursions between 59°F to 86°F (15°C and 30°C) are permitted.

US_cFAQ_IML605_STORAGE_PACKAGING
US_cFAQ_IML605_STORAGE_PACKAGINGen-US

Dosage Form

Imlunestrant 200 mg tablet is a white capsule-shaped, film coated-capsule shaped tablet with

  • "LILLY" on one side, and
  • an elongated 4-point starbust and "1717" on the other side.1

Packaging Configuration

Imlunestrant 200 mg tablets are supplied in either a 28-count or 56-count bottle configuration:

  • 28-count: NDC 0002-1717-28, and
  • 56-count: NDC 0002-1717-56.1

Storage Conditions

Store imlunestrant tablets at 68°F to 77°F (20°C to 25°C). Excursions between 59°F to 86°F (15°C and 30°C) are permitted.1

Disposal

Dispose unused imlunestrant tablets via a take-back option if available. Otherwise, follow FDA instructions for disposing medication in the household trash, www.fda.gov/drugdisposal. Do NOT flush down the toilet.1

Enclosed Prescribing Information

INLURIYO™ (imlunestrant) tablets, for oral use, Lilly

Reference

1Inluriyo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2025.

Date of Last Review: July 16, 2025

Are you satisfied with this content?

Can't find what you're looking for? Contact us for answers to your medical questions.

  • Copyright
  • Terms of Use
  • Privacy Statement
  • Consumer Health Privacy Notice
  • Accessibility Statement
  • Sitemap

    This site is intended for US Healthcare Professionals only.

    4.0.47 9/2025 | GLOOTH00001 04/2015 | © Lilly USA, LLC 2025. All rights reserved.

    Product names listed above are trademarks or registered trademarks owned by or licensed to Eli Lilly and Company, its subsidiaries, or affiliates

    California Consumer Privacy Act (CCPA) Opt-Out Icon Your Privacy Choices
    Cookie Settings
    facebook twitter linkedin
    visit www.phactmi.org
    Lilly